NP-Led Program Reduces Heart Failure Readmissions Among Veterans
An NP-led effort to reduce all-cause readmissions for patients with HF emphasizes patient engagement and goal setting for self-care.
An NP-led effort to reduce all-cause readmissions for patients with HF emphasizes patient engagement and goal setting for self-care.
January 2021 FDA approvals of import to physician assistants and nurse practitioners include treatments for HIV, heart failure, dry eye disease, and light chain amyloidosis.
Researchers analyzed a hypothyroidism comorbidity network for positive and negative associations with other chronic conditions.
In the 8 weeks following the first reported UK death due to COVID-19, there was a decrease in referral of patients with acute heart failure.
The sNDA is supported by data from the phase 3 EMPEROR-Reduced trial which compared the efficacy and safety of empagliflozin to placebo, in addition to recommended therapy, in 3730 patients with chronic heart failure with reduced ejection fraction.
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
Women are at increased risk for heart failure and death after first-time myocardial infarction.
Higher serum levels of VCAM-1 may be associated with incident HFpEF.
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
FGF23 levels may be associated with lower LV systolic function, higher LV mass, and lower LA function.